Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage

Arthritis and Rheumatism

Volumn 41, Issue 6, 1998, Pages 1007-1018

  Glant, Tibor T ^a   Cs Szabó, Gabriella ^a   Nagase, Hideaki ^b   Jacobs, Joshua J ^a   Mikecz, Katalin ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTHRITIS; ARTICLE; CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; DEGLYCOSYLATION; DISEASE PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNITY; MOUSE; NONHUMAN; OSTEOARTHRITIS; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; RHEUMATOID ARTHRITIS; STRAIN DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AGGRECANS; ANIMALS; ARTHRITIS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FETUS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LECTINS, C-TYPE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MIDDLE AGED; OSTEOARTHRITIS; PEPTIDE FRAGMENTS; PROTEOGLYCANS; REFERENCE VALUES;

EID: 0031747789     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6     Document Type: Article

References (54)

1. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice: clinical features and histopathology. Arthritis Rheum 1987;30:201-12.
2. Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987;30:306-18.
3. Glant TT, Mikecz K, Thonar EJA, Kuettner KE. Immune responses to cartilage proteoglycans in inflammatory animal models and human diseases. In: Woessner JF, Howell DS, editors. Cartilage degradation: basic and clinical aspects. New York: Marcel Dekker; 1992. p. 435.
4. Buzás E, Mikecz K, Brennan FR, Glant TT. Mediators of autopathogenic effector cells in proteoglycan-induced arthritic and clinically asymptomatic BALB/c mice. Cell Immunol 1994;158: 292-304.
5. Mikecz K, Brennan FR, Kim JH, Glant TT. Anti-CD44 treatment abrogates tissue edema and leukocyte infiltration in murine arthritis. Nat Med 1995;1:558-63.
6. Glant TT, Buzás EI, Finnegan A, Negroiu G, Cs-Szabó G, Mikecz K. Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol 1998;160:3812-19.
7. Glant TT, Mikecz K, Bartlett RR, Deák F, Thonar EJ-MA, Williams JM, et al. Immunomodulation of proteoglycan-induced progressive polyarthritis by leflunomide. Immunopharmacology 1992;23:105-16.
8. Mikecz K, Glant TT. Immunoregulation of proteoglycan-induced arthritis in BALB/c mice. Am J Ther 1996;3:42-51.
9. Mikecz K, Glant TT, Buzás E, Poole AR. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (non-immunized) BALB/c mice. Arthritis Rheum 1990;33:866-76.
10. Mikecz K, Glant TT. Migration and homing of lymphocytes to lymphoid and synovial tissues in proteoglycan-induced murine arthritis. Arthritis Rheum 1994;37:1395-403.
11. Glant TT, Fülöp C, Mikecz K, Buzás E, Molnár G, Erhardt P. Proteoglycan-specific autoreactive antibodies and T-lymphocytes in experimental arthritis and human rheumatoid joint diseases. Biochem Soc Trans 1990;18:796-9.
12. Glant TT, Fülöp C, Cs-Szabó G, Buzás EI, Ragasa DR, Mikecz K. Mapping of arthritogenic/autoimmune epitopes of cartilage aggrecans in proteoglycan-induced arthritis. Scand J Rheumatol 1995; 24:43-9.
13. Cs-Szabó G, Roughley PJ, Plaas AHK, Glant TT. Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum 1995;38:660-8.
14. Heinegård DK, Hascall VC. Aggregation of cartilage proteoglycans. III. Characteristics of the proteins isolated from trypsin digests of aggregates. J Biol Chem 1974;249:4250-6.
15. Heinegård D, Hascall VC. Characterization of chondroitin sulfate isolated from trypsin-chymotrypsin digests of cartilage proteoglycans. Arch Biochem Biophys 1974;165:427-41.
16. Roughley PJ, White RJ. Age-related changes in the structure of the proteoglycan subunits from human articular cartilage. J Biol Chem 1980;255:217-24.
17. Olszewski J, McDonnell J, Stevens K, Visco D, Moore V. A matrix metalloproteinase-generated aggrecan neoepitope as a marker of skeletal maturation and aging in cartilage. Arthritis Rheum 1996; 39:1234-7.
18. Witter J, Roughley PJ, Webber C, Roberts N, Keystone E, Poole AR. The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum 1987;30:519-29.
19. Roughley PJ, Nguyen Q, Mort JS. Mechanisms of proteoglycan degradation in human articular cartilage. J Rheumatol 1991;18: 52-4.
20. Rizkalla G, Reiner A, Bogoch E, Poole AR. Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis: evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 1992;90:2268-77.
21. Sandy JD, Flannery CR, Neame PJ, Lohmander LS. The structure of aggrecan fragments in human synovial fluid: evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 1992;89:1512-6.
22. Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, et al. Aggrecan degradation in human cartilage: evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 1997;100:93-106.
23. Poole AR, Dieppe P. Biological markers in rheumatoid arthritis. Semin Arthritis Rheum 1994;23:17-31.
24. Poole AR, Ionescu M, Swan A, Dieppe PA. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan: implications for pathogenesis. J Clin Invest 1994;94:25-33.
25. Cs-Szabó G, Melching LI, Roughley PJ, Glant TT. Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum 1997;40:1037-45.
26. Glant TT, Mikecz K, Poole AR. Monoclonal antibodies to different protein-related epitopes of human articular cartilage proteoglycans. Biochem J 1986;234:31-41.
27. Hascall VC, Sajdera SW. Protein polysaccharide complex from bovine nasal cartilage: the function of glycoprotein in the formation of aggregates. J Biol Chem 1969;244:2384-96.
28. Lohmander LS, Neame PJ, Sandy JD. The structure of aggrecan fragments in human synovial fluid: evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum 1993;36:1214-22.
29. Glant TT, Mikecz K, Roughley PJ, Buzás E, Poole AR. Agerelated changes in protein-related epitopes of human articular-cartilage proteoglycans. Biochem J 1986;236:71-5.
30. Mathews MB. Comparative biochemistry of chondroitin sulfate-proteins of cartilage and notocord. Biochem J 1971;125:37-46.
31. Okada Y, Nagase H, Harris EJ. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components: purification and characterization. J Biol Chem 1986;261:14245-55.
32. Gunja-Smith Z, Nagase H, Woessner JF Jr. Purification of the neutral proteoglycan-degrading metalloproteinase from human articular cartilage tissue and its identification as stromelysin matrix metalloproteinase-3. Biochem J 1989;258:115-9.
33. Saus J, Quinones S, Otani Y, Nagase H, Harris ED Jr, Kurkinen M. The complete primary structure of human matrix metalloproteinase 3: identity with stromelysin. J Biol Chem 1988;263:6742-5.
34. Bitter T, Muir H. A modified uronic-acid-carbazole reaction. Anal Biochem 1962;4:320-34.
35. Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967;18:267-73.
36. Thonar EJA, Lenz ME, Maldonado B, Otten L, Glant T, Kuettner KE. Measurement of antigenic keratan sulfate by an enzyme-linked immunosorbent assay. In: Maroudas A, Kuettner KE, editors. Methods in cartilage research. London: Academic Press; 1990. p. 170.
37. Poole CA, Glant TT, Schofield JR. Chondrons from articular cartilage. IV. Immunolocalization of proteoglycan epitopes in isolated canine tibial chondrons. J Histochem Cytochem 1991;39: 1175-87.
38. Negroiu G, Roughley PJ, Cs-Szabo G, Otto JM, Glant TT. Localization of autoimmune/arthritogenic B cell epitopes of cartilage proteoglycans by autoreactive antibodies to mouse aggrecan [abstract]. Arthritis Rheum 1996;39 Suppl 9:S285.
39. Caterson B, Baker JR, Christner JE, Lee Y, Lentz M. Monoclonal antibodies as probes for determining the microheterogeneity of the link proteins of cartilage proteoglycans. J Biol Chem 1985;260: 11348-56.
40. Williams JM, Zurawski J, Mikecz K, Giant TT. Functional assessment of joint use in experimental inflammatory murine arthritis. J Orthop Res 1993;11:172-80.
41. Singer II, Kawka DW, Bayne EK, Donatelli SA, Weidner JR, Williams HA, et al. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J Clin Invest 1995;95:2178-86.
42. Buzás EI, Brennan FR, Mikecz K, Garzó M, Negroiu G, Holló K, et al. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J Immunol 1995;155:2679-87.
43. Vilim V, Lenz ME, Vytasek R, Masuda K, Pavelka K, Kuettner KE, et al. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids. Arch Biochem Biophys 1997;341:8-16.
44. Buzás EI, Holló K, Rubliczky L, Garzó M, Fülöp C, Nyirkos P, et al. Effect of pregnancy on proteoglycan-induced progressive polyarthritis in BALB/c mice: remission of disease activity. Clin Exp Immunol 1993;94:252-60.
45. Banerjee S, Poole AR. Immunity to cartilage proteoglycans. J Rheumatol 1992;19 Suppl 33:36-9.
46. + T cells. Cell Immunol 1992;144:347-57.
47. Brennan FR, Mikecz K, Buzás EI, Ragasa D, Cs-Szabó G, Negroiu G, et al. Antigen-specific B cells present cartilage proteoglycan (aggrecan) to an autorcactivc T cell hybridoma derived from a mouse with proteoglycan-induced arthritis. Clin Exp Immunol 1995;101:414-21.
48. Wooley PH, Siegner SW, Whalen JD, Karvonen RI, Fernandez-Madrid F. Dependence of proteoglycan induced arthritis in BALB/c mice on the development of autoantibodies to high density proteoglycans. Ann Rheum Dis 1992;51:983-91.
49. Leroux J-Y, Guerassimov A, Cartman A, Delaunay N, Webber C, Rosenberg LC, et al. Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. J Clin Invest 1996;97:621-32.
50. Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993;36:181-9.
51. Cole AA, Chubinskaya S, Schumacher B, Huch K, Cs-Szabó G, Yao J, et al. Chondrocyte matrix metalloproteinase-8: human articular chondrocytes express neutrophil collagenase. J Biol Chem 1996;271:11023-6.
52. Chubinskaya S, Huch K, Mikecz K, Cs-Szabó G, Hasty KA, Kuettner KE, et al. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin 1β in human cartilage from knee and ankle joints. Lab Invest 1996;74: 232-40.
53. Verheijden GFM, Rijnders AWM, Bos E, Coenen-de Roo CJJ, van Staveren CJ, Miltenburg AMM, et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997;40:1115-25.
54. Guerassimov A, Delaunay N, Banerjee S, Leroux J-Y, Cartman A, Rosenberg LC, et al. Immunity to cartilage link protein can induce an erosive polyarthritis in BALB/c mice [abstract]. Arthritis Rheum 1994;37 Suppl 9:S397.